Description
GLUCOVANCE 500 mg / 5 mg Tablets (60’s)
GLUCOVANCE is a fixed-dose combination oral antidiabetic medication that contains Metformin Hydrochloride (500 mg) and Glibenclamide (5 mg). It is specifically formulated for adults with type 2 diabetes mellitus who require dual therapy to achieve adequate glycemic control.
Metformin works by decreasing hepatic glucose production and improving peripheral insulin sensitivity, while Glibenclamide, a sulfonylurea, stimulates the pancreas to release insulin. Together, these agents offer a powerful and complementary approach to controlling blood sugar levels.
GLUCOVANCE is typically prescribed when monotherapy with either agent is insufficient. It is recommended alongside dietary measures, physical activity, and regular blood glucose monitoring. The 60-tablet pack provides a convenient monthly supply for ongoing treatment adherence.
Key Features:
-
Combines Metformin 500 mg and Glibenclamide 5 mg in a single tablet
-
Dual-action formula for enhanced glycemic control in type 2 diabetes
-
Metformin improves insulin sensitivity; Glibenclamide stimulates insulin secretion
-
Reduces risk of complications such as neuropathy, nephropathy, and retinopathy
-
Suitable for patients not adequately managed with monotherapy
-
60-tablet pack ensures convenience and consistent dosing
Use only under the supervision of a healthcare provider. Not recommended for type 1 diabetes or in cases of diabetic ketoacidosis.
Reviews
There are no reviews yet.